D
David J. Margolis
Researcher at University of Pennsylvania
Publications - 581
Citations - 74527
David J. Margolis is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Population & Atopic dermatitis. The author has an hindex of 97, co-authored 521 publications receiving 62556 citations. Previous affiliations of David J. Margolis include Rutgers University & Harvard University.
Papers
More filters
Patent
Blis derivees de bacteries pour le traitement de l'acne
TL;DR: In this paper, an invention concerne un traitement de l'acne, concurring l'utilisation de substances inhibitrices de type bacteriocine (Bacteriocin-like Inhibitory Substances ; BLIS) isolees de S. salivarius en tant que bactericides ou bacteriostatiques, a savoir P. acnes.
Journal ArticleDOI
Association between atopic dermatitis, autoimmune illnesses, Epstein-Barr virus, and cytomegalovirus.
Anatomical Study Mouse and Rat Retina: A Physiological and Light Signaling in Scotopic Conditions in the Rabbit,
Dario A. Protti,Nicolas Flores-Herr,Wei Li,Stephen C. Massey,Dao-Qi Zhang,Tongrong Zhou,Douglas G. McMahon,David J. Margolis,Peter B. Detwiler,Jacqueline L. Harding,Melissa M. Reynolds,Jozsef Vigh,Ryan E. Tooker,Mikhail Y. Lipin,Valerie Leuranguer,Eva Rozsa,Jayne R. Bramley +16 more
Journal ArticleDOI
Increased bursting in layer 2/3 neurones of awake neocortex.
TL;DR: A surge of recent studies have made a further push into the realm of awake behaving animals, with juxtasomal recording enabling recording of suprathreshold spiking activity followed by intracellular dye fills and morphological reconstruction.
Posted ContentDOI
Integrated single-cell multiomic analysis of HIV latency reversal reveals novel regulators of viral reactivation
Ashokkumar Manickam,J Peterson,Yuriko Harigaya,David M Murdoch,David J. Margolis,A. Oesterling,Zhicheng Guo,C. Rudin,Yuchao Jiang,Edward P. Browne +9 more
TL;DR: In this paper , an integrated single-cell RNA-seq/ATAC-seq approach was employed to simultaneously profile the transcriptomic and epigenomic characteristics of ~4000 latently infected cells after reactivation using three different latency-reversing agents (LRAs).